Heron Therapeutics Inc (NASDAQ:HRTX), a biotechnology company, announced the pricing of an underwritten offering of 4,800,000 shares of its common stock, offered at …
CTI BioPharma Corp (NASDAQ:CTIC) shares increased 9.6% to $2.
Heron Therapeutics Inc (NASDAQ:HRTX) shares have taken off, adding 60% to trade at $19.76, following the news that the company’s late-stage study of its treatment for chemotherapy-induced nausea and …
Heron Therapeutics Inc (NASDAQ:HRTX) shares soared over 38% to $17.10 in pre-market trading after the company announced positive, top-line results from its recently completed Phase …
Heron Therapeutics Inc (NASDAQ:HRTX) announced positive, top-line results from its recently completed Phase 3 MAGIC study. MAGIC evaluated the efficacy and safety of the …
By Sonya Colberg Heron Therapeutics Inc (NASDAQ:HRTX), a tiny drug company with no approved product and nothing but losses to report, may be …
